Please login to the form below

Not currently logged in
Email:
Password:

BlueRock Therapeutics

This page shows the latest BlueRock Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bayer takes control of BlueRock stem cell joint venture

Bayer takes control of BlueRock stem cell joint venture

Deal values BlueRock at $1bn. Bayer is buying out private equity partner Versant Ventures and founders in its cell therapy joint venture BlueRock Therapeutics for $240m, three years after setting up ... The venture unit followed that a few weeks later

Latest news

  • Bayer helps bankroll new stem cell company BlueRock Bayer helps bankroll new stem cell company BlueRock

    BlueRock Therapeutics comes into being with one of the largest debut financings ever granted to a biotech company, and is the second start-up to be backed by Bayer's investment ... BlueRock will have research and development operations in Toronto, New

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics